Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women
Part of paid clinical trials in New Orleans, Louisiana.
- Sponsor
- Devyser Inc.
- Study ID
- NCT06690099
- Status
- Recruiting
Conditions
- Pregnancy
- Rhesus D Genotype
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The purpose of this research is to collect blood samples and data from pregnant women who are Rh negative. The blood will be used for the future research and the development of non-invasive prenatal tests to identify Rh blood type status of the baby during pregnancy.
Key Dates
- Start date
- Apr 7, 2025
- Status verified
- May 2025
- Primary completion
- Jun 30, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 500 participants (estimated)
Arms
- Arm: Pregnant womenPregnant women who are RhD negative and between 12 and 28 weeks gestation
Primary Outcome Measure
Fetal RhD determination from maternal whole blood [ Time Frame: 18 months ]
Central Contacts
- Tasha Kalista Sr. Director, Clinical Affairs8135508310
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ochsner Health | New Orleans | Louisiana | 70115 |
Find similar trials in New Orleans, LA
By research site
Related Studies
- Effects of Oncological Treatment During Pregnancy on Mother and ChildRecruiting · University Hospital, Gasthuisberg · Camden, New Jersey
- Prenatal Exposure Effects Psychophysiology StudyEnrolling By Invitation · University of North Carolina, Chapel Hill · Chapel Hill, North Carolina
- Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With PhenylketonuriaRecruiting · Emory University · Atlanta, Georgia
- Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy ProjectRecruiting · University of California, San Diego · La Jolla, California